Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Price Competition in Pharmaceuticals: The Case of Anti‐infectives

16 references·14 citing·41 second hop

FromToDepth

this work references cited by second hop

References

1989Handbook of Industrial Organization1,587 cited
1991Entry and Competition in Concentrated Markets1,465 cited
1978Entry Deterrence in the Ready-to-Eat Breakfast Cereal Industry869 cited
1992Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act574 cited
1982The estimation of the degree of oligopoly power462 cited
1983A Study of Cartel Stability: The Joint Executive Committee, 1880-1886433 cited
1989A study of cartel stability: the Joint Executive Committee, 1880–1886424 cited
1991Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry399 cited
1997Generic Entry and the Pricing of Pharmaceuticals388 cited
2005Generic Drug Industry Dynamics312 cited
1981Departures from marginal-cost pricing in the American automobile industry251 cited
1998Strategic Pricing of New Pharmaceuticals249 cited
1997Characteristics of Demand for Pharmaceutical Products: An Examination of Four Cephalosporins230 cited
1999Entry Decisions in the Generic Pharmaceutical Industry228 cited
2000Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry226 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2001Are The Benefits Of Newer Drugs Worth Their Cost? Evidence From The 1996 MEPS214 cited

Cited by

2013Higher US Branded Drug Prices And Spending Compared To Other Countries May Stem Partly From Quick Uptake Of New Drugs113 cited
2008Pharmaceutical pricing policies in a global market107 cited
2012Pharmaceutical Prices under Regulation: Tiered Co-payments and Reference Pricing in Germany100 cited
2018The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review86 cited
2004What Explains the Use of Direct‐to‐Consumer Advertising of Prescription Drugs?79 cited
2008Pharmaceutical Pricing Policies in a Global Market72 cited
2016Reference pricing with endogenous generic entry70 cited
2007Entry and competition in generic biologics67 cited
2019Competition and price among brand-name drugs in the same class: A systematic review of the evidence66 cited
2007‘Branded Generics’ as a strategy to limit cannibalization of pharmaceutical markets58 cited
2010From Free Entry to Patent Protection: Welfare Implications for the Indian Pharmaceutical Industry58 cited
2016The substance of entrepreneurship and the entrepreneurship of substances17 cited
2022University patenting and licensing practices in the United Kingdom during the first year of the COVID-19 pandemic13 cited
2016Protecting products versus platforms5 cited